GYRE Gyre Therapeutics, Inc. - Common Stock
NASDAQ · Biotechnology · View on SEC EDGAR ↗ close Oct 2, 2026 10-K/10-Q Aug 7, 2026
$7.11
· of 52w range
· above low
· to high
$5.4452w low
$9.4252w high
Market Cap (MRQ)
$754M
P/E (TTM)
-35.5
EPS (TTM)
$-0.20
Revenue (TTM)
$119M
your badges
52W Range
$5–$9
Analyst Rating
BUY
Price Target
$19
P/E
-35.5
ROE
-28.3%
Net Profit Margin
-23.7%
Your badge strip is empty — pin a metric anywhere on this page.
GYRE Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$7.11
Market Cap (MRQ)
$754M
P/E (TTM)
-35.5
EPS (TTM)
$-0.20
Revenue (TTM)
$119M
ROE (TTM)
-28.3%
52W Range
$5–$9
GYRE Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
Stock splits
| Ex-date | Split | Type |
|---|---|---|
| Oct. 31, 2023 | 1-for-15 | Reverse |
| Feb. 13, 2017 | 1-for-15 | Reverse |
| Aug. 21, 2015 | 1-for-7 | Reverse |
10-Year Performance Revenue, net income, margins and EPS trends
Revenue$117M2017-12-31 → 2025-12-31
EPS$0.022021-12-31 → 2025-12-31
Free Cash Flow$-180.0K2016-12-31 → 2025-12-31
Net margin-23.7%2020-12-31 → 2025-12-31
Valuation & Ratios
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | GYRE | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/E (TTM) | -35.55Y avg ≈167.4 | ≈167.4 | · | · | |
| P/S (TTM) | 6.35Y avg ≈8.9 | ≈8.9 | 8.0 | Undervalued | |
| P/B (MRQ) | 7.05Y avg ≈-28.9 | ≈-28.9 | 3.2 | Overvalued | |
| Price / FCF (TTM) | -47.95Y avg ≈-1214.5 | ≈-1214.5 | · | · | |
| Price / Cash Flow (TTM) | -52.05Y avg ≈104.6 | ≈104.6 | · | · | |
| Price / Tangible Book (MRQ) | 7.35Y avg ≈10.1 | ≈10.1 | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
| Metric | 5Y trend | GYRE | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Operating Margin (TTM) | -14.0%5Y avg ≈-11.4% | ≈-11.4% | -1043.3% | Top tier | |
| EBITDA Margin (TTM) | -11.1%5Y avg ≈-9.9% | ≈-9.9% | -1043.3% | Top tier | |
| Pretax Margin (TTM) | -13.5%5Y avg ≈-11.2% | ≈-11.2% | · | · | |
| Net Profit Margin (TTM) | -23.7%5Y avg ≈-16.7% | ≈-16.7% | -989.0% | Top tier | |
| ROA (TTM) | -16.1%5Y avg ≈-20.7% | ≈-20.7% | -33.0% | Top tier | |
| ROE (TTM) | -28.3%5Y avg ≈65.0% | ≈65.0% | -39.4% | Top tier | |
| ROIC | 7.4%5Y avg ≈135.1% | ≈135.1% | -32.0% | Top tier |
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | GYRE | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Current Ratio (MRQ) | 4.35Y avg ≈3.4 | ≈3.4 | 11.3 | Low liquidity | |
| Quick Ratio (MRQ) | 3.05Y avg ≈2.5 | ≈2.5 | 6.6 | Low liquidity |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
| Metric | 5Y trend | GYRE | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Revenue YoY | 10.2%5Y avg ≈248.7% | ≈248.7% | · | · | |
| Revenue CAGR 3Y | 4.5%5Y avg ≈74.5% | ≈74.5% | · | · | |
| Revenue CAGR 5Y | 41.0% | · | · | · | |
| EPS YoY | -60.0% | · | · | · | |
| Net Income YoY | -44.8% | · | · | · | |
| EPS CAGR 3Y | -12.6% | · | · | · | |
| Net Income CAGR 3Y | 31.8% | · | · | · |
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
| Metric | 5Y trend | GYRE | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Asset Turnover | 0.85Y avg ≈0.9 | ≈0.9 | 0.0 | Top tier | |
| Receivables Turnover | 4.6 | · | · | · | |
| Revenue / Employee | ≈$186.5K | · | · | · |
value · ≈ 5Y avg · industry median · verdict relative to median
Dividends Yield, payout ratio, dividend history, 5Y CAGR
Annualized Payout≈$3.60
| Ex-date | Amount | Currency | Yield |
|---|---|---|---|
| Jan 13, 2023 | $3.60 | USD | ≈642.3% |
| Sep 21, 2022 | $21.45 | USD | ≈286.0% |
| Aug 20, 2015 | $896.18 | USD | ≈59.3% |
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
13.3%
Next Report
Nov 05, 2026
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| June 30, 2026 | Aug 18, 2026 | $-0.12 | $-0.09 | -30.7% |
| March 31, 2026 | May 8, 2026 | $-0.10 | $-0.07 | -33.7% |
| Dec. 31, 2025 | $0.05 | $0.06 | -13.5% | |
| Sept. 30, 2025 | $0.08 | $0.03 | 194.1% | |
| June 30, 2025 | $0.02 | $0.03 | -34.6% | |
| March 31, 2025 | $0.03 | $0.03 | -2.0% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $117M | $106M | $113M | $102M | $7M | $21M | · | $6.0K | $1M | · | · | $275.0K | |
| Cost of Revenue | $5M | $4M | $5M | $5M | · | · | · | · | · | · | · | · | |
| Gross Profit | · | $102M | $109M | $97M | · | · | · | · | · | · | · | · | |
| R&D Expense | $14M | $12M | $14M | · | $69M | $53M | $44M | $21M | $13M | $12M | $6M | $5M | |
| SG&A Expense | $21M | $16M | $15M | $17M | $19M | $16M | $13M | $12M | $10M | $9M | $10M | $4M | |
| Operating Expenses | $105M | $90M | $176M | $88M | $95M | $78M | $57M | $34M | $23M | $21M | $16M | $9M | |
| Operating Income | $11M | $16M | $-67M | $9M | $-88M | $-57M | $-57M | $-34M | $-22M | $-20M | $-14M | $-8M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | · | $1M | $23.0K | |
| Other Non-op | $-2M | $-2M | $-2M | · | $-78.0K | $-91.0K | $-39.0K | $2M | $-1.0K | $86.0K | $131.0K | $575.0K | |
| Pretax Income | $14M | $23M | $-77M | $9M | $-88M | · | · | · | · | · | · | $-29M | |
| Income Tax | $5M | $5M | $9M | $5M | · | · | · | · | · | · | · | $3M | |
| Net Income | $10M | $18M | $-85M | $4M | $-88M | $-56M | $-55M | $-30M | $-22M | $-17M | $-15M | $-7M | |
| EPS (Basic) | $0.06 | $0.14 | $-1.41 | $0.04 | $-2.87 | · | · | · | · | · | · | · | |
| EPS (Diluted) | $0.02 | $0.05 | $-1.41 | $0.03 | $-2.87 | · | · | · | · | · | · | · | |
| Shares (Basic) | 89,344,622 | 85,094,948 | 65,831,675 | 63,588,119 | 30,640,977 | · | · | · | · | · | · | · | |
| Shares (Diluted) | 103,180,037 | 102,293,526 | 65,831,675 | 75,686,406 | 30,640,977 | · | · | · | · | · | · | · | |
| EBITDA | $14M | $18M | $-66M | $-8M | · | $-57M | $-57M | · | $-22M | $-20M | $-13M | $-29M |
Balance Sheet
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $49M | $12M | $34M | $25M | $44M | $30M | $15M | $31M | $14M | $10M | $29M | $2M | |
| Short-term Investments | $15M | $15M | · | · | $3M | $49M | $61M | $89M | $18M | $7M | $3M | $51M | |
| Receivables | $31M | $20M | $15M | · | $2M | $3M | $15M | · | · | · | · | $141.0K | |
| Inventory | $10M | $6M | $4M | $6M | · | · | · | · | · | · | · | · | |
| Prepaid Expense | $10M | $3M | · | $2M | $3M | $7M | $4M | $4M | $1M | $958.0K | $2M | $103.0K | |
| Other Current Assets | $1M | $1M | $1M | $843.0K | · | · | · | · | · | · | · | · | |
| Current Assets | $149M | $65M | $57M | $50M | $51M | $90M | $96M | $124M | $39M | $38M | $69M | $2M | |
| PP&E (Net) | $28M | $24M | $23M | $18M | $970.0K | $433.0K | $304.0K | $386.0K | $276.0K | $444.0K | $698.0K | $911.0K | |
| PP&E (Gross) | $39M | $29M | $28M | $22M | · | · | · | $671.0K | $2M | $2M | $6M | $8M | |
| Accum. Depreciation | $11M | $6M | $4M | $4M | · | · | $400.0K | $300.0K | $2M | $2M | $6M | $7M | |
| Intangibles | $5M | $273.0K | $273.0K | $297.0K | · | · | · | · | · | · | · | · | |
| Other Non-current Assets | $8M | $3M | $995.0K | $3M | $472.0K | $528.0K | $257.0K | $543.0K | $128.0K | · | · | $12.0K | |
| Total Assets | $220M | $125M | $117M | $85M | $56M | $95M | $99M | $125M | $40M | $38M | $70M | $3M | |
| Accounts Payable | $1M | $108.0K | $355.0K | $122.0K | $6M | $6M | $4M | $1M | $747.0K | $837.0K | $939.0K | $249.0K | |
| Accrued Liabilities | · | · | · | · | · | · | · | · | · | · | · | $3M | |
| Current Liabilities | $24M | $20M | $20M | $12M | $14M | $18M | $29M | $5M | $9M | $22M | $38M | $2M | |
| Capital Leases | $2M | $885.0K | $199.0K | $121.0K | $408.0K | $981.0K | $1M | · | · | · | · | · | |
| Other Non-current Liabilities | $2M | $7.0K | $49.0K | $55.0K | · | · | · | · | · | · | · | · | |
| Total Liabilities | $31M | $27M | $38M | $13M | $15M | $19M | $30M | $5M | $9M | $22M | $38M | $3M | |
| Long-term Debt | · | · | · | · | · | · | · | · | · | · | · | $0 | |
| Common Stock | $91.0K | $86.0K | $77.0K | $64.0K | $31.0K | $22.0K | $12.0K | $12.0K | $6.0K | $1.0K | $1.0K | $34.0K | |
| Paid-in Capital | $173M | $136M | $68M | $33M | $444M | $391M | $327M | $323M | $204M | $164M | $162M | $7M | |
| Retained Earnings | $-113M | $-73M | $-86M | $7M | $-403M | $-315M | $-259M | $-203M | $-173M | $-148M | $-131M | $-116M | |
| AOCI | $-908.0K | $-3M | $-2M | $-392.0K | · | $5.0K | $34.0K | $-4.0K | · | $-1.0K | $1.0K | $4.0K | |
| Stockholders' Equity | $62M | $63M | $-16M | $43M | $41M | $76M | $68M | $120M | $31M | $16M | $31M | $-109M | |
| Liabilities + Equity | $220M | $125M | $117M | $85M | $56M | $95M | $99M | $125M | $40M | $38M | $70M | $3M | |
| Shares Outstanding | 91,314,007 | 86,307,544 | 76,595,616 | 63,588,119 | 31,409,707 | 22,097,820 | 12,040,835 | 11,954,528 | 6,081,230 | 801,756 | 762,005 | 370,944 |
Cash Flow
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $2M | $2M | $1M | $1M | $290.0K | $138.0K | $146.0K | $149.0K | $173.0K | $389.0K | $470.0K | $680.0K | |
| Stock-based Comp | $7M | $831.0K | $7M | $13M | $3M | $4M | $3M | $3M | $863.0K | $635.0K | $326.0K | $244.0K | |
| Deferred Tax | $-1M | $-1M | $-834.0K | $-890.0K | · | · | · | · | · | · | · | $72.0K | |
| Amort. of Intangibles | $576.0K | $38.0K | $100.0K | $200.0K | · | · | · | · | · | · | · | · | |
| Restructuring | · | · | · | $1M | $4M | · | · | · | $0 | · | · | · | |
| Other Non-cash | $-17M | $-23M | $104M | $-26M | · | $-3M | $8M | · | $585.0K | $-3M | $-5M | $-6M | |
| Operating Cash Flow | $1M | $-4M | $26M | $11M | $-84M | $-55M | $-44M | $-29M | $-20M | $-18M | $-19M | $-6M | |
| CapEx | $1M | $2M | $9M | $5M | $839.0K | · | $64.0K | $376.0K | $23.0K | $468.0K | $272.0K | $4.0K | |
| Investing Cash Flow | $-474.0K | $-20M | $-20M | $-14M | $48M | $10M | $27M | $-71M | $-11M | · | · | · | |
| Net Debt Issued | · | · | · | · | · | · | · | · | · | · | · | $-1M | |
| Stock Issued | · | $773.0K | · | · | · | · | · | · | $5M | $958.0K | · | $296.0K | |
| Stock Repurchased | · | · | · | · | · | · | · | · | · | · | $82.0K | · | |
| Net Stock Activity | · | $773.0K | · | · | · | · | · | · | $5M | $958.0K | $-82.0K | $296.0K | |
| Dividends Paid | · | · | · | $45M | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $24M | $2M | $2M | $-45M | $50M | $60M | $327.0K | $111M | $21M | · | · | · | |
| Net Change in Cash | $25M | $-22M | $8M | $-5M | $14M | $15M | $-16M | $11M | $-10M | $-19M | $28M | $-1M | |
| Taxes Paid | $6M | $9M | $6M | $6M | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $-180.0K | $-6M | $17M | · | · | · | $-44M | · | $-20M | $-19M | $-19M | $-34M | |
| Levered FCF | · | · | · | · | · | · | · | · | · | · | · | $-35M |
Profitability
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | 96.3% | 95.9% | · | · | · | · | · | · | · | · | · | |
| Operating Margin | 9.8% | 15.3% | -59.3% | · | · | -273.9% | · | · | · | · | · | -10805.1% | |
| Net Margin | 8.5% | 16.9% | -75.3% | · | · | -268.5% | · | · | · | · | · | -11862.9% | |
| Pretax Margin | 12.4% | 21.9% | -67.8% | · | · | · | · | · | · | · | · | -10596.0% | |
| EBITDA Margin | 12.0% | 16.8% | -58.3% | · | · | -273.2% | · | · | · | · | · | -10677.5% | |
| ROA | 6.8% | 14.8% | -84.9% | -19.6% | · | -58.2% | -49.4% | · | -55.6% | -31.5% | -40.7% | -25.3% | |
| ROE | 11.7% | 75.4% | 387.3% | -214.5% | · | -66.1% | -73.8% | · | -92.0% | -71.4% | 37.9% | -1073.6% | |
| ROIC | 7.4% | 19.7% | 471.8% | 41.4% | · | · | · | · | · | · | · | -30.5% |
Liquidity & Solvency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 5.6 | 3.3 | 2.9 | 1.7 | · | 5.0 | 3.3 | · | 4.5 | 1.7 | 1.8 | 37.1 | |
| Quick Ratio | 4.6 | 2.4 | 1.7 | 1.3 | · | 4.6 | 3.2 | · | 3.7 | 0.8 | 0.9 | 36.9 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | · | -9.3 | -1291.9 |
Efficiency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.8 | 0.9 | 1.1 | · | · | 0.2 | · | · | · | · | · | 0.0 | |
| Inventory Turnover | · | 0.7 | 0.9 | · | · | · | · | · | · | · | · | · | |
| Receivables Turnover | 4.6 | 6.1 | · | · | · | 2.3 | · | · | · | · | · | 1.3 |
Per Share
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $1.16 | $0.73 | $-0.21 | $-0.57 | · | $3.44 | $5.68 | · | $5.06 | $20.04 | $2.75 | $3.23 | |
| Revenue / Share | $1.13 | $1.03 | $1.72 | · | · | · | · | · | · | · | · | · | |
| Cash Flow / Share | $0.01 | $-0.04 | $0.39 | $-1.05 | · | · | · | · | · | · | · | · | |
| Cash / Share | $0.41 | $0.14 | $0.44 | $0.57 | · | $1.37 | $1.28 | · | $2.38 | $12.80 | $2.55 | $1.67 | |
| Dividend / Share | · | · | · | $0.24 | · | · | · | · | · | · | · | · | |
| Dividend Paid / Share | · | · | · | $1.43 | · | · | · | · | · | · | · | · | |
| EPS (TTM) | $0.02 | $0.05 | $-1.41 | $0.03 | $-2.87 | $-1.46 | $-1.46 | $-1.46 | $-1.46 | $-1.46 | $-1.46 | $-1.46 |
Growth Rates
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 10.2% | -6.8% | 10.9% | 1294.0% | -65.0% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 4.5% | 143.4% | 75.6% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 41.0% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | -60.0% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | -12.6% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | -44.8% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | 31.8% | · | · | · | · | · | · | · | · | · | · | · |
Valuation (TTM)
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $117M | $106M | $113M | $102M | $7M | $21M | · | $6.0K | $1M | $248.0K | $248.0K | $275.0K | |
| Net Income TTM | $10M | $18M | $-85M | $4M | $-88M | $-56M | $-55M | $-30M | $-22M | $-17M | $-15M | $-7M | |
| Market Cap | $645M | $1.04B | $1.97B | $300M | · | $2.09B | $1.23B | · | $1.24B | $117M | $8.05B | $139.98B | |
| P/E | 353.0 | 242.0 | -18.2 | 265.0 | -4.8 | -64.8 | -70.0 | -81.1 | -140.1 | -100.2 | -482.4 | -2837.2 | |
| P/S | 5.5 | 9.9 | 17.3 | 2.9 | · | 99.8 | · | · | 1222.2 | 472.8 | 32458.2 | 509025.8 | |
| P/B | 6.1 | 16.5 | -124.3 | -13.8 | · | 27.5 | 18.0 | · | 40.4 | 7.3 | 256.2 | 1283.2 | |
| P / Tangible Book | 6.4 | 16.6 | · | 7.1 | 10.4 | 27.5 | · | · | · | · | · | · | |
| P / Cash Flow | 638.3 | -286.8 | 76.0 | -9.1 | · | -38.0 | -28.2 | · | -62.4 | -6.3 | -421.1 | -4059.5 | |
| P / FCF | -3581.5 | -175.3 | 113.3 | · | · | · | -28.2 | · | -62.3 | -6.2 | -415.1 | -4059.0 | |
| Dividend Yield | · | · | · | 15.0% | · | · | · | · | · | · | · | · | |
| Earnings Yield | 0.28% | 0.41% | -5.5% | 0.38% | -21.0% | -1.5% | -1.4% | -1.2% | -0.71% | -1.0% | -0.21% | -0.04% | |
| Payout Ratio | · | · | · | -546.4% | · | · | · | · | · | · | · | · | |
| Annual Payout | · | · | · | $45M | · | · | · | · | · | · | · | · |
Income Statement
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $29M | $23M | $37M | $31M | $30M | $22M | $28M | $25M | $25M | $27M | $27M | $32M | $29M | $25M | · | · | |
| Cost of Revenue | $2M | $1M | $2M | $2M | $1M | $894.0K | $1M | $958.0K | $770.0K | $979.0K | $1M | $1M | $1M | $1M | · | · | |
| Gross Profit | · | · | · | $29M | $26M | $21M | · | $25M | $24M | $26M | $26M | $31M | $28M | $24M | · | · | |
| R&D Expense | · | $7M | $5M | $2M | $8M | $3M | $4M | $3M | $3M | $2M | $5M | $3M | $4M | $3M | · | $803.0K | |
| SG&A Expense | $8M | $7M | $7M | $4M | $7M | $5M | $5M | $4M | $3M | $3M | $10M | $1M | $2M | $2M | $4M | $4M | |
| Operating Expenses | $43M | $32M | $41M | $22M | $32M | $20M | $30M | $20M | $21M | $18M | $118M | $18M | $23M | $17M | $119M | $5M | |
| Operating Income | $-14M | $-9M | $118.0K | $7M | $-2M | $2M | $665.0K | $4M | $3M | $8M | $-92M | $13M | $5M | $7M | $-22M | $-5M | |
| Other Non-op | $-943.0K | $29.0K | $-2M | $727.0K | $-488.0K | $107.0K | $-2M | $-75.0K | $-72.0K | $122.0K | $-237.0K | $-1M | $629.0K | · | · | $-1.0K | |
| Pretax Income | $-14M | $-9M | $-66.0K | $8M | $-2M | $5M | $772.0K | $4M | $6M | $12M | $-100M | $11M | $6M | $6M | $-23M | $-5M | |
| Income Tax | $-164.0K | $621.0K | $1M | $2M | $662.0K | $901.0K | $203.0K | $1M | $1M | $3M | $699.0K | $4M | $2M | $2M | $5M | $0 | |
| Net Income | $-14M | $-19M | $-1M | $6M | $-2M | $5M | $569.0K | $3M | $5M | $10M | $-101M | $8M | $4M | $4M | $-28M | $-5M | |
| EPS (Basic) | $-0.12 | $-0.10 | $-0.01 | $0.04 | $-0.02 | $0.03 | $0.00 | $0.01 | $0.04 | $0.09 | $-1.54 | $0.06 | $0.03 | $0.04 | $-0.98 | $-0.16 | |
| EPS (Diluted) | $-0.12 | $-0.10 | $-0.01 | $0.03 | $-0.03 | $0.00 | $0.00 | $0.01 | $0.01 | $0.03 | $-1.51 | $0.05 | $0.02 | $0.03 | $-0.99 | $-0.16 | |
| Shares (Basic) | 100,637,599 | 91,317,142 | · | 90,850,040 | 89,119,344 | 86,420,530 | · | 85,643,646 | 85,502,403 | 83,265,879 | · | 63,588,119 | 63,588,119 | 63,588,119 | · | 31,484,542 | |
| Shares (Diluted) | 100,637,599 | 91,344,584 | · | 103,971,546 | 89,203,138 | 101,970,672 | · | 102,640,373 | 102,205,888 | 102,594,197 | · | 78,904,324 | 78,904,324 | 78,921,366 | · | 31,484,542 | |
| EBITDA | · | $-9M | · | $7M | $2M | $3M | · | $4M | $3M | $8M | · | $-2M | $-3M | $181.0K | · | $-5M |
Balance Sheet
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $43M | $38M | $37M | $40M | $36M | $15M | $12M | $16M | $16M | $30M | $34M | $2M | $7M | $8M | $25M | $23M | |
| Short-term Investments | $14M | $12M | $15M | $20M | $18M | $15M | $15M | $9M | $9M | $8M | · | · | · | · | · | · | |
| Receivables | $28M | $23M | $31M | $26M | $25M | $20M | $20M | · | · | · | $15M | · | · | · | · | · | |
| Inventory | $11M | $11M | · | · | $9M | $8M | · | $6M | $6M | $5M | $4M | · | · | · | $6M | · | |
| Prepaid Expense | $8M | $4M | · | $3M | $3M | $8M | · | · | · | · | · | · | $697.0K | $915.0K | · | $2M | |
| Other Current Assets | · | · | $1M | · | · | · | $1M | $2M | $2M | $2M | $1M | · | · | · | $843.0K | · | |
| Current Assets | $122M | $92M | $102M | $99M | $91M | $68M | $65M | $55M | $54M | $63M | $57M | $5M | $8M | $14M | $50M | $30M | |
| PP&E (Net) | $27M | $24M | $24M | $24M | $23M | $24M | $24M | $24M | $24M | $24M | $23M | · | · | $1.0K | $18M | $124.0K | |
| PP&E (Gross) | $40M | $32M | $31M | $31M | $30M | $30M | $29M | $30M | $28M | $28M | $28M | · | · | · | $22M | · | |
| Accum. Depreciation | $13M | $8M | $8M | $7M | $6M | $6M | $6M | $5M | $5M | $5M | $4M | · | · | · | $4M | · | |
| Intangibles | $5M | $5M | $5M | $5M | $5M | $5M | $273.0K | $184.0K | $186.0K | $196.0K | $205.0K | · | · | · | $297.0K | · | |
| Other Non-current Assets | $7M | $5M | $2M | $5M | $5M | $6M | $3M | $3M | $1M | $802.0K | $995.0K | $168.0K | $168.0K | $168.0K | $3M | $168.0K | |
| Total Assets | $199M | $162M | $166M | $159M | $153M | $130M | $125M | $125M | $121M | $122M | $117M | $10M | $12M | $19M | $85M | $31M | |
| Accounts Payable | $1M | $265.0K | $124.0K | $556.0K | $71.0K | $122.0K | $108.0K | $303.0K | $271.0K | $330.0K | $355.0K | $158.0K | $5.0K | $16.0K | $122.0K | $41.0K | |
| Current Liabilities | $29M | $20M | $18M | $16M | $17M | $19M | $20M | $15M | $16M | $19M | $20M | $2M | $3M | $7M | $12M | $2M | |
| Capital Leases | $2M | $72.0K | $303.0K | $539.0K | $771.0K | $780.0K | $885.0K | $1M | $1M | $175.0K | $199.0K | · | · | · | $121.0K | · | |
| Other Non-current Liabilities | $70.0K | $1M | $1M | $1M | $1M | $1M | $7.0K | $2.0K | $47.0K | $48.0K | $49.0K | · | · | · | $55.0K | · | |
| Total Liabilities | $34M | $25M | $24M | $22M | $23M | $25M | $27M | $27M | $28M | $33M | $38M | $6M | $7M | $11M | $13M | $2M | |
| Common Stock | $106.0K | $91.0K | $91.0K | $91.0K | $91.0K | $87.0K | $86.0K | $85.0K | $85.0K | $85.0K | $77.0K | $37.0K | $37.0K | $37.0K | $64.0K | $31.0K | |
| Paid-in Capital | $241M | $175M | $172M | $167M | $161M | $138M | $136M | $134M | $134M | $133M | $68M | $385M | $385M | $385M | $33M | $400M | |
| Retained Earnings | $-138M | $-78M | $-68M | $-67M | $-70M | $-71M | $-73M | $-73M | $-74M | $-78M | $-86M | $-415M | $-413M | $-411M | $7M | $-370M | |
| AOCI | $1M | $586.0K | $-779.0K | $-2M | $-2M | $-2M | $-3M | $-946.0K | $-2M | $-2M | $-2M | · | · | · | $-392.0K | · | |
| Stockholders' Equity | $108M | $101M | $106M | $102M | $92M | $68M | $63M | $63M | $60M | $57M | $-16M | $4M | $-28M | $-26M | $43M | $29M | |
| Liabilities + Equity | $199M | $162M | $166M | $159M | $153M | $130M | $125M | $125M | $121M | $122M | $117M | $10M | $12M | $19M | $85M | $31M | |
| Shares Outstanding | 106,033,763 | 91,337,121 | 91,314,007 | 90,890,381 | 90,822,828 | 87,636,209 | 86,307,544 | 85,769,526 | 85,537,774 | 85,423,246 | 76,595,616 | 37,978,142 | 37,974,892 | 37,759,825 | 63,588,119 | 31,490,053 |
Cash Flow
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $1M | $672.0K | $656.0K | $649.0K | $641.0K | $535.0K | $461.0K | $445.0K | $228.0K | $415.0K | $298.0K | $772.0K | $581.0K | $276.0K | $867.0K | $40.0K | |
| Stock-based Comp | $2M | $3M | $5M | $1M | $906.0K | $507.0K | $567.0K | $237.0K | $16.0K | $11.0K | $7M | $98.0K | $89.0K | $210.0K | $12M | $224.0K | |
| Amort. of Intangibles | $179.0K | $175.0K | $172.0K | $170.0K | $167.0K | $67.0K | $-80.5K | $10.0K | $8.5K | $100.0K | $-7.0K | $14.0K | $48.0K | $45.0K | · | · | |
| Other Non-cash | · | $10M | · | · | · | $-5M | · | · | · | $-7M | · | · | · | $-7M | · | · | |
| Operating Cash Flow | $-17M | $3M | $-6M | $5M | $2M | $-129.0K | $-3M | $2M | $-5M | $3M | $3M | $31M | $21M | $10M | $42M | $-7M | |
| CapEx | $262.0K | $178.0K | $144.0K | $668.0K | $256.0K | $122.0K | $-65.0K | $693.0K | $1M | $231.0K | $2M | $2M | $2M | $2M | · | · | |
| Investing Cash Flow | $10M | $-3M | $2M | $-1M | $-3M | $2M | $-2M | $-2M | $-8M | $-7M | $1M | $-26M | $-16M | $-8M | $-69M | $0 | |
| Stock Issued | · | · | · | · | $22M | $509.0K | · | · | · | · | · | · | · | · | · | · | |
| Net Stock Activity | · | · | · | · | · | $509.0K | · | · | · | · | · | · | · | · | · | · | |
| Dividends Paid | · | · | · | · | · | · | · | · | · | · | · | $2M | $4M | $8M | · | · | |
| Financing Cash Flow | $-8.0K | $21.0K | $318.0K | $365.0K | $22M | $1M | $964.0K | $324.0K | $156.0K | $658.0K | $15M | $-1M | $-4M | $-8M | · | $-45M | |
| Net Change in Cash | $-6M | $431.0K | $-3M | $4M | $21M | $3M | $-4M | $-231.0K | $-14M | $-4M | $7M | $16M | $12M | $3M | $16M | $-52M | |
| Taxes Paid | · | $1M | $1M | $687.0K | $447.0K | $3M | $761.0K | $537.0K | $6M | $1M | $961.0K | $1M | $4M | $463.0K | · | · | |
| Free Cash Flow | · | $3M | · | · | · | $-251.0K | · | · | · | $3M | · | · | · | · | · | · |
Profitability
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | · | 94.7% | 95.7% | 96.0% | · | 96.2% | 97.0% | 96.4% | · | · | · | · | · | · | |
| Operating Margin | · | -41.5% | · | 22.7% | 8.1% | 10.3% | · | 16.6% | 12.9% | 29.7% | · | · | · | · | · | · | |
| Net Margin | · | -43.8% | · | 19.4% | 5.9% | 16.9% | · | 11.2% | 18.0% | 36.6% | · | · | · | · | · | · | |
| Pretax Margin | · | -41.0% | · | 25.0% | 8.4% | 21.0% | · | 15.4% | 23.9% | 45.9% | · | · | · | · | · | · | |
| EBITDA Margin | · | -38.6% | · | 22.7% | 8.1% | 12.7% | · | 16.6% | 12.9% | 31.2% | · | · | · | · | · | · | |
| ROA | · | -6.8% | · | 4.2% | 1.1% | 3.0% | · | 4.2% | 6.8% | 14.1% | · | -7.7% | -5.2% | 0.88% | · | -8.9% | |
| ROE | · | -11.6% | · | 7.2% | 2.1% | 6.0% | · | 8.6% | 28.3% | 64.8% | · | -9.6% | -9.7% | 46.0% | · | -10.8% | |
| ROIC | · | -9.8% | · | 5.3% | 1.7% | 2.7% | · | 4.9% | 4.1% | 11.3% | · | -46.2% | 9.0% | -0.65% | · | · |
Liquidity & Solvency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | · | 4.6 | · | 6.2 | 5.4 | 3.6 | · | 3.7 | 3.4 | 3.2 | · | 2.9 | 2.7 | 2.0 | · | 18.4 | |
| Quick Ratio | · | 3.7 | · | 5.4 | 4.7 | 2.6 | · | 1.7 | 1.6 | 1.9 | · | 1.2 | 2.5 | 1.2 | · | 14.0 |
Efficiency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.4 | 0.4 | 0.4 | · | · | · | · | · | · | |
| Inventory Turnover | · | 0.1 | · | · | 0.2 | 0.1 | · | 0.3 | 0.3 | 0.4 | · | · | · | · | · | · | |
| Receivables Turnover | · | 1.0 | · | 2.3 | 2.0 | 2.1 | · | · | · | · | · | · | · | · | · | · |
Per Share
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | · | $1.11 | · | $1.12 | $1.01 | $0.78 | · | $0.74 | $0.71 | $0.66 | · | $0.09 | $-0.75 | $-0.69 | · | $0.93 | |
| Revenue / Share | · | $0.25 | · | $0.29 | $0.26 | $0.22 | · | $0.25 | $0.24 | $0.26 | · | · | · | · | · | · | |
| Cash Flow / Share | · | $0.03 | · | · | · | $-0.00 | · | · | · | $0.03 | · | · | · | $-0.16 | · | · | |
| Cash / Share | · | $0.41 | · | $0.44 | $0.40 | $0.17 | · | $0.18 | $0.19 | $0.35 | · | $0.06 | $0.18 | $0.21 | · | $0.73 | |
| Dividend Paid / Share | · | · | · | · | · | · | · | · | · | · | · | $0.00 | $0.00 | $0.24 | · | $1.43 | |
| EPS (TTM) | $-0.22 | $-0.11 | · | $0.00 | $-0.02 | $0.02 | · | $-1.46 | $-1.42 | $-1.41 | · | $-0.89 | $-1.10 | $0.52 | · | $0.38 |
Valuation (TTM)
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $112M | $120M | · | $110M | $105M | $101M | · | $105M | $112M | $116M | · | · | · | · | · | · | |
| Net Income TTM | $-29M | $-16M | · | $9M | $6M | $13M | · | $-84M | $-79M | $-80M | · | $-12M | $-25M | $23M | · | $12M | |
| Market Cap | · | $637M | · | $678M | $668M | $677M | · | $1.08B | $1.02B | $1.49B | · | $273M | $199M | $119M | · | $236M | |
| P/E | -30.0 | -63.4 | · | · | -367.5 | 386.0 | · | -8.6 | -8.4 | -12.4 | · | -8.1 | -4.8 | 6.1 | · | 19.7 | |
| P/S | · | 5.3 | · | 6.2 | 6.3 | 6.7 | · | 10.2 | 9.1 | 12.9 | · | · | · | · | · | · | |
| P/B | · | 6.3 | · | 6.7 | 7.3 | 9.9 | · | 17.0 | 16.9 | 26.4 | · | 77.7 | -7.0 | -4.6 | · | 8.0 | |
| P / Tangible Book | 6.8 | 6.6 | · | 7.0 | 7.7 | 10.7 | · | 17.1 | 17.0 | 26.5 | · | 77.7 | · | · | · | 8.0 | |
| P / Cash Flow | · | 200.2 | · | · | · | -5244.6 | · | · | · | 517.8 | · | · | · | -19.1 | · | · | |
| Earnings Yield | -3.3% | -1.6% | · | 0.00% | -0.27% | 0.26% | · | -11.6% | -11.9% | -8.1% | · | -12.4% | -20.9% | 16.5% | · | 5.1% | |
| Payout Ratio | · | · | · | · | · | · | · | · | · | · | · | · | · | 2986.2% | · | · |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Revenue | $117M | $106M | $113M | $102M | $7M |
| Gross Margin % | · | 96.3% | 95.9% | · | · |
| Operating Margin % | 9.8% | 15.3% | -59.3% | · | · |
| Net Income | $10M | $18M | $-85M | $4M | $-88M |
| Diluted EPS | $0.02 | $0.05 | $-1.41 | $0.03 | $-2.87 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Current Ratio | 5.6 | 3.3 | 2.9 | 1.7 | · |
| Quick Ratio | 4.6 | 2.4 | 1.7 | 1.3 | · |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Free Cash Flow | $-180.0K | $-6M | $17M | · | · |
Institutional owners (13F) 62 filers · $65.5M total · As of Sept. 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Holders
62
Value held
$65.5M
New positions
11
Exited positions
7
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 11 (-4 vs prior Q) | 7 (+4 vs prior Q) | 31 (+13 vs prior Q) | 9 (-2 vs prior Q) | +5.3M |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| HSG Holding Ltd | $24,714,470 | 3,750,299 | 37.75% | Shares |
| VANGUARD GROUP INC | $8,483,219 | 1,201,589 | 12.96% | Shares |
| BlackRock, Inc. | $6,550,085 | 993,943 | 10.01% | Shares |
| Octagon Capital Advisors LP | $6,289,601 | 954,416 | 9.61% | Shares |
| VANGUARD CAPITAL MANAGEMENT LLC | $5,778,949 | 876,927 | 8.83% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $3,513,176 | 532,950 | 5.37% | Shares |
| STATE STREET CORP | $1,617,199 | 245,402 | 2.47% | Shares |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $1,214,445 | 184,286 | 1.86% | Shares |
| NORTHERN TRUST CORP | $1,117,249 | 169,537 | 1.71% | Shares |
| SBI Securities Co., Ltd. | $1,098,883 | 166,750 | 1.68% | Shares |
| VANGUARD FIDUCIARY TRUST CO | $995,571 | 151,073 | 1.52% | Shares |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $816,850 | 123,953 | 1.25% | Shares |
| GOLDMAN SACHS GROUP INC | $568,289 | 86,235 | 0.87% | Shares |
| Bank of New York Mellon Corp | $413,523 | 62,750 | 0.63% | Shares |
| MORGAN STANLEY | $274,743 | 41,691 | 0.42% | Shares |
| ALLIANCEBERNSTEIN L.P. | $171,392 | 24,590 | 0.26% | Shares |
| STRS OHIO | $170,022 | 25,800 | 0.26% | Shares |
| DIMENSIONAL FUND ADVISORS LP | $166,516 | 25,268 | 0.25% | Shares |
| Nuveen, LLC | $161,488 | 24,505 | 0.25% | Shares |
| UBS Group AG | $123,649 | 18,763 | 0.19% | Shares |
| MILLENNIUM MANAGEMENT LLC | $121,836 | 18,488 | 0.19% | Shares |
| DEUTSCHE BANK AG\ | $118,218 | 17,939 | 0.18% | Shares |
| RHUMBLINE ADVISERS | $111,131 | 16,865 | 0.17% | Shares |
| WELLS FARGO & COMPANY/MN | $107,397 | 16,297 | 0.16% | Shares |
| FMR LLC | $98,679 | 14,974 | 0.15% | Shares |
| ROYAL BANK OF CANADA | $87,000 | 13,195 | 0.13% | Shares |
| BANK OF AMERICA CORP /DE/ | $82,539 | 12,525 | 0.13% | Shares |
| Polymer Capital Management (US) LLC | $77,630 | 11,780 | 0.12% | Shares |
| Vanguard Global Advisers, LLC | $65,788 | 9,983 | 0.10% | Shares |
| Police & Firemen's Retirement System of New Jersey | $59,382 | 9,011 | 0.09% | Shares |
| CITIGROUP INC | $56,582 | 8,586 | 0.09% | Shares |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $55,659 | 8,446 | 0.09% | Shares |
| JPMORGAN CHASE & CO | $50,510 | 7,831 | 0.08% | Shares |
| Russell Investments Group, Ltd. | $24,930 | 3,783 | 0.04% | Shares |
| BNP PARIBAS FINANCIAL MARKETS | $22,973 | 3,486 | 0.04% | Shares |
| BARCLAYS PLC | $21,273 | 3,228 | 0.03% | Shares |
| NEW YORK STATE COMMON RETIREMENT FUND | $17,793 | 2,700 | 0.03% | Shares |
| Tower Research Capital LLC (TRC) | $16,271 | 2,469 | 0.02% | Shares |
| Legal & General Group Plc | $13,536 | 2,054 | 0.02% | Shares |
| Ameritas Investment Partners, Inc. | $4,501 | 683 | 0.01% | Shares |
| Activest Wealth Management | $3,512 | 533 | 0.01% | Shares |
| Arax Advisory Partners | $1,621 | 246 | 0.00% | Shares |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $1,094 | 166 | 0.00% | Shares |
| Sterling Capital Management LLC | $1,061 | 161 | 0.00% | Shares |
| GAMMA Investing LLC | $962 | 146 | 0.00% | Shares |
| CWM, LLC | $725 | 104 | 0.00% | Shares |
| Physician Wealth Advisors, Inc. | $541 | 82 | 0.00% | Shares |
| Bare Financial Services, Inc | $521 | 79 | 0.00% | Shares |
| GoalVest Advisory LLC | $367 | 50 | 0.00% | Shares |
| GoalVest Advisory LLC | $330 | 50 | 0.00% | Shares |
Activists & 5%+ owners 21 positions
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| Songjiang Ma, Yueying Zhu | May 7, 2026 | 6.33% | Amendment | M&A / sale | SEC |
| Ying Luo, Ping Lan | May 6, 2026 | 8.60% | Amendment | M&A / sale | SEC |
| GNI USA, Inc., GNI Group Ltd. ×4 filings | May 6, 2026 | 69.10% | Amendment | M&A / sale | SEC |
| Ying Luo (“Mr. Luo”), Ping Lan | Sept. 6, 2024 | · | Initial filing | Passive investment | SEC |
| Songjiang Ma (“Mr. Ma”), Yueying Zhu | Sept. 6, 2024 | · | Initial filing | Passive investment | SEC |
| GNI Group Ltd., GNI Hong Kong Limited, GNI USA, Inc. ×2 filings | Oct. 31, 2023 | · | Initial filing | · | SEC |
| JDS1, LLC, CCUR Holdings, Inc., CIDM II, LLC, Julian D. Singer, David S. Oros ×13 filings | Oct. 7, 2022 | · | Initial filing | Passive investment | SEC |
| JEC II Associates, LLC, The Heidi S. Shippell-Heiland 2008 Irrevocable Trust, Michael Torok ×4 filings | Sept. 22, 2022 | · | Initial filing | · | SEC |
| Julian Singer, JDS1, LLC 2, CCUR Holdings, Inc., David S. Oros ×3 filings | Jan. 27, 2022 | · | Initial filing | · | SEC |
| 22NW Fund, LP, 22 NW, LP, 22NW Fund GP, LLC, 22NW GP, Inc., Aron R. English ×2 filings | Aug. 5, 2020 | · | Initial filing | · | SEC |
| CCUR Holdings, Inc., Wayne Barr, Jr., JDS1, LLC, David S. Oros, Julian Singer ×3 filings | Jan. 17, 2020 | · | Initial filing | · | SEC |
| Morgenthaler Management Partners VIII, LLC (“MMP VIII”), Morgenthaler Partners VIII, L.P. (“MP VIII”), Robert C. Bellas, Jr. (“Bellas”), Ralph E. Christoffersen (“Christoffersen”), John Lutsi (“Lutsi”), Gary J. Morgenthaler (“Morgenthaler”), Robert D. Pavey (“Pavey”), Gary R. Little (“Little”) | Feb. 14, 2018 | · | Initial filing | · | SEC |
| HealthCare Ventures VIII, L.P., HealthCare Partners VIII, L.P., HealthCare Partners VIII, LLC, James H. Cavanaugh, Ph.D., Harold R. Werner, John W. Littlechild, Christopher Mirabelli, Ph.D., Augustine Lawlor ×2 filings | Feb. 9, 2018 | · | Initial filing | · | SEC |
| May 23, 2017 | · | Initial filing | · | SEC | |
| New Enterprise Associates 10, Limited Partnership, NEA Partners 10, Limited Partnership, Michael James Barrett, Peter J. Barris, Scott D. Sandell ×4 filings | March 29, 2017 | · | Initial filing | · | SEC |
| Essex Woodlands Health Ventures VIII, LLC, Essex Woodlands Health Ventures VIII, L.P., Essex Woodlands Health Ventures Fund VIII, L.P., Jeff Himawan, Ph.D., James Currie, Martin Sutter, Immanuel Thangaraj, Petri Vainio, Ron Eastman, Steve Wiggins, Guido Neels | Aug. 31, 2015 | · | Initial filing | Passive investment | SEC |
| Morgenthaler Management Partners VIII, LLC, Morgenthaler Partners VIII, L.P., Ralph Christoffersen, Robert Bellas, John Lutsi, Gary Morgenthaler, Robert Pavey, Gary Little | Aug. 31, 2015 | · | Initial filing | Passive investment | SEC |
| Rosetta Capital V LP, Rosetta Capital V GP LP, Rosetta Capital V GP Limited, Rosetta Capital Limited | Aug. 28, 2015 | · | Initial filing | Passive investment | SEC |
| BIOTECHNOLOGY VALUE FUND, L.P., BIOTECHNOLOGY VALUE FUND II, L.P., BVF INVESTMENTS, L.L.C., INVESTMENT 10, L.L.C., MSI BVF SPV, LLC, BVF PARTNERS, L.P., BFV INC., MARK N. LAMPERT ×6 filings | Aug. 21, 2015 | · | Initial filing | · | SEC |
| Undisclosed reporting person, Undisclosed reporting person, Undisclosed reporting person, Undisclosed reporting person | Jan. 29, 2008 | · | Initial filing | Passive investment | SEC |
| Undisclosed reporting person, Undisclosed reporting person, Undisclosed reporting person, Undisclosed reporting person | Jan. 28, 2008 | · | Initial filing | Passive investment | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Company insiders 66 insiders · 26 officers · 32 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Ying Luo | Chief Executive Officer | June 8, 2026 A | 2,565,226 | 0 | 2 | $-82,927 |
| Han Ying | Chief Executive Officer | Aug. 14, 2024 A | · | 0 | 0 | $0 |
| Charles C Wu | Chief Executive Officer | Nov. 20, 2023 A | · | 0 | 0 | $0 |
| Donald J Debethizy | President and CEO | May 4, 2012 A | 798 | 0 | 0 | $0 |
| Thomas Wilson Eastling | Chief Financial Officer | May 4, 2026 A | 15,000 | 0 | 0 | $0 |
| Ruoyu Chen | Chief Financial Officer | Jan. 7, 2026 A | · | 0 | 0 | $0 |
| Seline E. Miller | SVP Finance; Interim CFO & PAO | Aug. 31, 2023 D | 0 | 0 | 0 | $0 |
| Clinton Musil | Chief Financial Officer | Feb. 8, 2021 A | · | 0 | 0 | $0 |
| Fletcher Payne | Chief Financial Officer | Aug. 12, 2019 A | 3,744 | 0 | 0 | $0 |
| Mauri K Hodges | Treasurer, CFO | Aug. 14, 2015 A | 1,159 | 0 | 0 | $0 |
| Alan A Musso | SVP, Fin+Admin, CFO & Treas | Oct. 17, 2014 A | 57,799 | 0 | 0 | $0 |
| Songjiang Ma | President | May 28, 2025 S | 2,806,084 | 0 | 0 | $0 |
| Weiguo Ye | Chief Operating Officer | June 18, 2026 M | 700,000 | 0 | 16 | $-869,947 |
| Joshua Benjamin Bergmann | GC and Corporate Secretary | June 8, 2026 A | · | 0 | 0 | $0 |
| Grant E. Blouse | Chief Scientific Officer | Aug. 9, 2022 P | 9,417 | 0 | 0 | $0 |
| Howard Levy | Chief Medical Officer | Aug. 9, 2021 P | 639 | 0 | 0 | $0 |
| Veronica Cai | Controller | March 13, 2020 P | 7,353 | 0 | 0 | $0 |
| Edwin Madison | Chief Scientific Officer | Oct. 22, 2015 A | 31,008 | 0 | 0 | $0 |
| Patrick C. Rock | Secretary, GC | Aug. 14, 2015 A | 45,000 | 0 | 0 | $0 |
| Steven M. Toler | VP, Clin Pharm Sciences | Oct. 17, 2014 A | 46,000 | 0 | 0 | $0 |
| David A. Hosford | VP, Clin Dev & Reg Affairs | Jan. 23, 2014 A | · | 0 | 0 | $0 |
| Karen A Hicks | VP, Human Resources | Jan. 17, 2013 A | 0 | 0 | 0 | $0 |
| Peter A Zorn | SVP, Lgl Affrs, GC & Secretary | Jan. 17, 2013 A | 0 | 0 | 0 | $0 |
| Merouane Bencherif | SVP and Senior Scien Fellow | Jan. 17, 2013 A | 15,938 | 0 | 0 | $0 |
| William S Caldwell | SVP - Drug Discovery and Dev. | Sept. 20, 2011 G | 500 | 0 | 0 | $0 |
| Geoffrey C Dunbar | SVP, Clin. Dev. & Reg. Affairs | March 29, 2011 A | 1,153 | 0 | 0 | $0 |
| Claire Weston | Director | Aug. 3, 2026 A | · | 0 | 0 | $0 |
| Maxwell Kirkby | Director | Aug. 3, 2026 A | · | 0 | 0 | $0 |
| Dan Weng | Director | June 10, 2026 A | · | 0 | 0 | $0 |
| Ping Zhang | Director | June 10, 2026 A | · | 0 | 0 | $0 |
| Rodney L Nussbaum | Director | June 10, 2026 A | · | 0 | 0 | $0 |
| Renate Parry | Director | June 10, 2026 A | · | 0 | 0 | $0 |
| Gordon Carmichael | Director | June 10, 2026 A | · | 0 | 0 | $0 |
| David M. Epstein | Director | June 10, 2026 A | · | 0 | 0 | $0 |
| Nassim Usman | Director | June 28, 2024 M | 1,636 | 0 | 0 | $0 |
| Andrea Hunt | Director | Aug. 31, 2023 D | 0 | 0 | 0 | $0 |
| Augustine Lawlor | Director | Aug. 31, 2023 D | 0 | 0 | 0 | $0 |
| Geoffrey Ling M.D. | Director | Jan. 7, 2022 A | 31,790 | 0 | 0 | $0 |
| Eddie Williams | Director | Jan. 7, 2022 A | 34,804 | 0 | 0 | $0 |
| Errol B Desouza | Director | Oct. 1, 2021 A | 29,801 | 0 | 0 | $0 |
| Jeanne Y Jew | Director | Sept. 9, 2021 A | · | 0 | 0 | $0 |
| Sharon Tetlow | Director | June 9, 2021 A | 3,635 | 0 | 0 | $0 |
| John P Richard | Director | March 13, 2020 P | 3,716 | 0 | 0 | $0 |
| Stephen A Hill | Director | Sept. 6, 2018 D | 1,190 | 0 | 0 | $0 |
| Harold E Selick | Director | Jan. 16, 2018 A | 16,614 | 0 | 0 | $0 |
| Jeff Himawan | Director | Aug. 20, 2015 J | 1,179,352 | 0 | 0 | $0 |
| Alan W Dunton | Director | Aug. 14, 2015 A | 10,000 | 0 | 0 | $0 |
| Charles A Blixt | Director | Aug. 14, 2015 A | 10,000 | 0 | 0 | $0 |
| Julia R Brown | Director | Aug. 14, 2015 A | 10,000 | 0 | 0 | $0 |
| SKALETSKY MARK B | Director | June 7, 2013 A | 11,332 | 0 | 0 | $0 |
| Steven Burrill | Director | July 31, 2012 M | 4,333 | 0 | 0 | $0 |
| Ralph Snyderman | Director | June 7, 2012 A | 0 | 0 | 0 | $0 |
| Ann Hanham | Director | April 18, 2006 C | 778,062 | 0 | 0 | $0 |
| GNI Hong Kong Ltd | 10% owner | Oct. 27, 2023 J | 0 | 0 | 0 | $0 |
| Scott D. Sandell | 10% owner | Dec. 5, 2013 S | 0 | 0 | 0 | $0 |
| Peter J Barris | 10% owner | Dec. 5, 2013 S | 0 | 0 | 0 | $0 |
| James M Barrett | 10% owner | Dec. 3, 2013 M | 0 | 0 | 0 | $0 |
| Richard C Kramlich | 10% owner | Nov. 19, 2012 X | 5,333 | 0 | 0 | $0 |
| NEA Partners 10, Limited Partnership | 10% owner | Jan. 17, 2008 J | 4,563,512 | 0 | 0 | $0 |
| Iii Eugene A Trainor | 10% owner | Jan. 17, 2008 J | 4,563,512 | 0 | 0 | $0 |
| New Enterprise Associates 10, Limited Partnership | 10% owner | Jan. 17, 2008 J | 4,563,512 | 0 | 0 | $0 |
| Mark W Perry | 10% owner | Jan. 17, 2008 J | 4,563,512 | 0 | 0 | $0 |
| Charles W Newhall III | 10% owner | Jan. 17, 2008 J | 4,563,512 | 0 | 0 | $0 |
| Peter Morris | 10% owner | Feb. 6, 2007 M | 2,000 | 0 | 0 | $0 |
| Jeffrey P Brennan | · | Jan. 17, 2013 A | 0 | 0 | 0 | $0 |
| Elaine V Jones | · | Nov. 29, 2007 X | 27,500 | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
ETF ownership Held by 11 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
| Fund | Weight | Units | As of | Source |
|---|---|---|---|---|
| IWO · iShares Trust | 0.01% | 120,729 SH | Sept. 11, 2026 | Daily |
| RSSL · Global X Funds | 0.00% | 8,775 NS | July 31, 2026 | N-PORT |
| IWM · iShares Trust | 0.00% | 387,159 SH | Sept. 11, 2026 | Daily |
| VXF · VANGUARD INDEX FUNDS | 0.00% | 238,693 SH | Aug. 19, 2026 | Daily |
| VTI · VANGUARD INDEX FUNDS | 0.00% | 614,654 SH | Aug. 19, 2026 | Daily |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.00% | 104,607 SH | Aug. 19, 2026 | Daily |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0.00% | 5,047 SH | Aug. 19, 2026 | Daily |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0.00% | 13,494 SH | Aug. 19, 2026 | Daily |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.00% | 805 SH | Aug. 19, 2026 | Daily |
| DFAS · Dimensional ETF Trust | 0.00% | 320 NS | July 31, 2026 | N-PORT |
| IWN · iShares Trust | · | 41,397 SH | Sept. 11, 2026 | Daily |
GYRE Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
rating · 9 analysts
BUY
Median target
$18.00
+153.2%
3 33.3%
Strong Buy
5 55.6%
Buy
1 11.1%
Hold
0 0.0%
Sell
0 0.0%
Strong Sell
12-Month Price Target
3 analysts · 2026-10-02Mean target $18.67 +162.5%
← Below all targets
Current price $7.11
Low$18.00
Mean$18.67
High$20.00
Peer comparison (GICS sub-industry) Key metrics vs sector peers
FY basis, prices as of each company's last fiscal year-end close.
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| GYRE | $645M | 353.0 | 10.2% | 8.5% | 11.7% | · |
| ANNX | $750M | -3.7 | · | · | -100.7% | · |
| AVTX | $336M | -3.1 | -86.6% | -132642.4% | -83.4% | · |
| CADL | $310M | -7.8 | · | · | -53.7% | · |
| GERN | $845M | -10.2 | -60.2% | · | -34.4% | · |
| DSGN | $567M | -7.7 | · | · | -32.8% | · |
| FDMT | $432M | -3.1 | 230194.6% | -164.4% | -30.2% | · |
| ACHV | · | -4.0 | · | · | · | · |
| SLDB | $445M | -2.8 | · | · | -79.5% | · |
| FTH | · | · | · | · | · | · |
| VSTM | $600M | -2.6 | 209.1% | -677.6% | -449.2% | · |
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Source: SEC 10-Q filed Aug 7, 2026